Modern CEO Stephen Bensell said tonight (Tuesday) in an interview with the British newspaper "Financial Times" that existing vaccines are far less effective in dealing with the Omicron strain than previous strains of Corona virus. Bensel warned that it would be months before drug companies could produce the vaccine Against the new strain.
Stephen Bensell said the high number of mutations in the spike protein, which the virus uses to infect human cells, and the rapid spread of the strain in South Africa, suggest that current vaccine production may need to be changed next year.
Bensel said he does not see a situation where the vaccine faces the same level as against the Delta strain.
He added: "I think it will be a significant drop. I just do not know how much because we have to wait for the data. But all the scientists I spoke to said 'it's not going to be good'."
Were we wrong?
Fixed!
If you found an error in the article, we'll be happy for you to share it with us